Another fight over privilege may be on the cards in a shareholder class action over the collapse of the Hastie Group, with Deloitte flagging its partners may claim privilege over certain parts of the accounting giant’s evidence.
Settlement talks in a class action brought by Shine Lawyers against Astora Women’s Health on behalf of women injured by allegedly defective pelvic mesh products are “well advanced”, while mediation in two similar actions is ongoing, a court has heard.
The Northern Territory government has hit back at a class action over allegedly underresourced and discriminatory healthcare services in the Indigenous community of Wadeye, saying it cannot be sued over its funding decisions.
A law firm that ran two class actions over the St Patrick’s Day bushfires has lost a bid to have group members foot the bill for $50,000 in adverse costs, with a judge saying there was “no basis” for the request.
Labour hire firm CoreStaff will pay $6.4 million to settle a class action accusing it of using the promise of long-term work to lure workers to Australia from Papua New Guinea, only to terminate their employment agreements less than three years after they made the move.
The federal government has argued it should not have to pay the “very high figure” former Royal Australian Navy sailors are seeking in compensation for a breached training contract that allegedly saw them denied a higher rate of pay.
The Morrison government has rejected class action claims that it owes a duty of care to Torres Strait Islanders to protect them against the negative effects of climate change, claiming the alleged duty cannot apply to high level government policy.
Judgments shooting down a class closure order and nixing notice of a possible class closure order were “plainly wrong” and “infected” by faulty reasoning, the Full Federal Court has heard.
An appeal in a class action over Ford’s alleged defective Powershift transmission could blow out by a week, with the applicant filing a cross appeal in a case that comes down to three provisions of the Australian Consumer law given little or no attention by the Full Court.
A second class action investigation against regenerative medicine company Mesoblast is underway, this one looking at claim it misled shareholders about the potential application of a developmental stem cell product to treat terminally-ill children.